Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 12, 2000, Pages 1645-1652

  Almasio, P L ^{a,b,c,d,e,f,g,h,i}   Floreani, A ^{a,b,c,d,e,f,g,h}   Chiaramonte, M ^{a,b,c,d,e,f,g,h}   Provenzano, G ^{a,b,c,d,e,f,g,h}   Battezzati, P ^{a,b,c,d,e,f,g,h}   Crosignani, A ^{a,b,c,d,e,f,g,h}   Podda, M ^{a,b,c,d,e,f,g,h}   Todros, L ^{a,b,c,d,e,f,g,h}   Rosina, F ^{a,b,c,d,e,f,g,h}   Saccoccio, G ^{a,b,c,d,e,f,g,h}   Manenti, F ^{a,b,c,d,e,f,g,h}   Ballardini, G ^{a,b,c,d,e,f,g,h}   Bianchi, F P ^{a,b,c,d,e,f,g,h}   Scheuer, P J ^{a,b,c,d,e,f,g,h}   Davies, S E ^{a,b,c,d,e,f,g,h}   Craxi A ^{a,b,c,d,e,f,g,h}  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h ROYAL FREE HOSPITAL   (United Kingdom)

ⁱ Istituto di Clinica Medica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; LIVER ENZYME; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CHOLESTASIS; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLYSIS; DISEASE COURSE; DRUG EFFICACY; ECHOGRAPHY; ENDOSCOPY; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

ADULT; AGED; BIOPSY; COLCHICINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; URSODEOXYCHOLIC ACID;

EID: 0034530379     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00869.x     Document Type: Article

References (33)

1. Ursodiol for the long-term treatment of primary biliary cirrhosis
2. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
3. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
4. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
5. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis
6. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis
7. Randomized controlled trials of ursodeoxycholic acid therapy for primary biliary cirrhosis: A meta-analysis
8. Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease
9. A prospective trial with colchicine for primary biliary cirrhosis
10. A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report
11. Evaluation of colchicine therapy in primary biliary cirrhosis
12. Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy
13. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid
14. A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis
15. Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. A prospective randomized study
16. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis
17. Serum bilirubin: A prognostic factor in primary biliary cirrhosis
18. Prognosis in primary biliary cirrhosis: Model for decision making
19. Beneficial effects of azathioprine and prediction of prognosis in primary biliary cirrhosis
20. Clinical diagnosis of primary biliary cirrhosis based on major criteria
21. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
22. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: A randomized trial
23. A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg
24. Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis
25. Effect of different doses of ursodeoxycholic acid in chronic liver disease
26. Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid
27. Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy
28. Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial
29. Mechanisms for reduced hepatic clearance and elevated plasma levels of bile acids in cirrhosis
30. Kinetics of hepatic bile acid handling in cholestatic liver disease: Effect of ursodeoxycholic acid
31. Clinical pharmacokinetics of therapeutic bile acids
32. Pharmacology of ursodeoxycholic acid an enterohepatic drug
33. Absorption of urso- and chenodeoxycholic acid and their taurine and glycine conjugates in rat jejunum ileum and colon